Skip to main content
Top
Published in: Diagnostic Pathology 1/2018

Open Access 01-12-2018 | Research

Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression

Authors: Lara Alessandrini, Nicolò Clemente, Tiziana Perin, Giorgio Giorda, Vincenzo Canzonieri, Francesco Sopracordevole

Published in: Diagnostic Pathology | Issue 1/2018

Login to get access

Abstract

Background

Extra-mammary Paget’s disease of the vulva (EMPDV) is an infrequent chronic disease that often recurs. The aim of the study was to assess the presence of neoangiogenesis and the expression of epithelial-mesenchymal transition (EMT) markers in EMPDV, and their potential correlation with stromal invasion.

Methods

All the women consecutively treated for EMPDV at our Institute, between January 2011 and December 2014, were studied for neoangiogenesis, analysed by microvessel density (MVD) using antibodies against CD31 and CD34. Immunohistochemical expression of E- / N-cadherin, β-catenin and SLUG was also evaluated. In each slide, three fields with the highest number of capillaries and small venules were identified at low power. In these three fields, the highest vessel density (HVD) and the average vessel density (AVD) at 200× and 400× magnification were counted. Immunohistochemical reactions for non-vascular markers were semiquantitatively scored by two pathologists, using a three-tier scale.

Results

Seventeen cases of EMPDV (including 10 cases of invasive disease) were included. The AVD at 200× and 400× and the HVD at 400× magnification were significantly associated with invasive EMPDV (p = 0.02, 0.03, 0.03 respectively). No significant correlation between MVD, EMT-markers expression and risk of recurrence was detected.

Conclusion

These results indicate that MVD, as a measure of neoangiogenesis, may be associated with histological progression of EMPDV. EMT could also be linked to an invasive potential of EMPDV but larger series are required to confirm this hypothesis.
Literature
1.
go back to reference Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180:24–7.CrossRefPubMed Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180:24–7.CrossRefPubMed
2.
go back to reference Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. World Health Organization classification of tumours of the female reproductive organs. Lyon: IARC Press; 2014. Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. World Health Organization classification of tumours of the female reproductive organs. Lyon: IARC Press; 2014.
3.
go back to reference Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed
4.
go back to reference Baehrendtz H, Einhorn N, Pettersson F, Silfversward C. Paget’s disease of the vulva: the Radiumhemmet series 1975–1990. Int J Gynecol Cancer. 1994;4:1–6.CrossRefPubMed Baehrendtz H, Einhorn N, Pettersson F, Silfversward C. Paget’s disease of the vulva: the Radiumhemmet series 1975–1990. Int J Gynecol Cancer. 1994;4:1–6.CrossRefPubMed
5.
go back to reference Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett. 2012;320:130–7.CrossRefPubMed Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett. 2012;320:130–7.CrossRefPubMed
6.
go back to reference Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Breitenecker G, Gitsch G. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol. 1996;63:204–9.CrossRefPubMed Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Breitenecker G, Gitsch G. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol. 1996;63:204–9.CrossRefPubMed
7.
go back to reference Saravanamuthu J, Reid WM, George DS, Crow JC, Rolfe KJ, MacLean AB, Perrett CW. The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis. Gynecol Oncol. 2003;89:251–8.CrossRefPubMed Saravanamuthu J, Reid WM, George DS, Crow JC, Rolfe KJ, MacLean AB, Perrett CW. The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis. Gynecol Oncol. 2003;89:251–8.CrossRefPubMed
8.
go back to reference Miettinen M, Lindenmayer AE, Chanbal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7:82–90.PubMed Miettinen M, Lindenmayer AE, Chanbal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7:82–90.PubMed
9.
go back to reference Boyer B, Thiery JP. Epithelium–mesenchyme interconversion as example of epithelial plasticity. APMIS. 1993;101:257–68.CrossRefPubMed Boyer B, Thiery JP. Epithelium–mesenchyme interconversion as example of epithelial plasticity. APMIS. 1993;101:257–68.CrossRefPubMed
11.
go back to reference Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.CrossRefPubMed Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.CrossRefPubMed
12.
go back to reference Ellis PE, Cano SD, Fear M, Kelsell DP, Ghali L, Crow JC, Perrett CW, MacLean AB. Reduced E-Cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget’s disease of the breast. Mod Pathol. 2008;21:1192–9.CrossRefPubMed Ellis PE, Cano SD, Fear M, Kelsell DP, Ghali L, Crow JC, Perrett CW, MacLean AB. Reduced E-Cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget’s disease of the breast. Mod Pathol. 2008;21:1192–9.CrossRefPubMed
13.
go back to reference Li B, Zhang Q, Ouyang L, Jia L, Han X, Zhou Y, Tong X, Song Z, Zhang S, Qiu X. Aberrant staining patterns of E-cadherin and β-catenin: a potential diagnostic value for distinguishing vulvar intraepithelial neoplasia from non-neoplastic vulvar lesions. Int J Clin Exp Pathol. 2013;6:1362–6.PubMedPubMedCentral Li B, Zhang Q, Ouyang L, Jia L, Han X, Zhou Y, Tong X, Song Z, Zhang S, Qiu X. Aberrant staining patterns of E-cadherin and β-catenin: a potential diagnostic value for distinguishing vulvar intraepithelial neoplasia from non-neoplastic vulvar lesions. Int J Clin Exp Pathol. 2013;6:1362–6.PubMedPubMedCentral
14.
go back to reference Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G. E-Cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305.PubMedPubMedCentral Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G. E-Cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011;2011:567305.PubMedPubMedCentral
15.
go back to reference Bosari S, Arthur L, Del-Ellis R, Wiley B, Heatley G, Silverman M. Microvessel quantification and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755–61.CrossRefPubMed Bosari S, Arthur L, Del-Ellis R, Wiley B, Heatley G, Silverman M. Microvessel quantification and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755–61.CrossRefPubMed
16.
go back to reference Ellis PE, Maclean AB, Wong Te Fong LF, Crow JC, Perrett CW. Angiogenesis in Paget's disease of the vulva and the breast: correlation with microvessel density. J Oncol. 2012;2012:651507.CrossRefPubMedPubMedCentral Ellis PE, Maclean AB, Wong Te Fong LF, Crow JC, Perrett CW. Angiogenesis in Paget's disease of the vulva and the breast: correlation with microvessel density. J Oncol. 2012;2012:651507.CrossRefPubMedPubMedCentral
17.
go back to reference Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H. N-Cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780–7.CrossRefPubMed Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H. N-Cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780–7.CrossRefPubMed
18.
go back to reference Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007;13:4769–76.CrossRefPubMed Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007;13:4769–76.CrossRefPubMed
19.
go back to reference Sopracordevole F, Di Giuseppe J, De Piero G, Canzonieri V, Buttignol M, Giorda G, Ciavattini A. Surgical treatment of Paget disease of the vulva: prognostic significance of stromal invasion and surgical margin status. J Low Genit Tract Dis. 2016;20:184–8.CrossRefPubMed Sopracordevole F, Di Giuseppe J, De Piero G, Canzonieri V, Buttignol M, Giorda G, Ciavattini A. Surgical treatment of Paget disease of the vulva: prognostic significance of stromal invasion and surgical margin status. J Low Genit Tract Dis. 2016;20:184–8.CrossRefPubMed
21.
go back to reference Delport ES. Extramammary Paget's disease of the vulva: an annotated review of the current literature. Australas J Dermatol. 2013;54:9–21.CrossRefPubMed Delport ES. Extramammary Paget's disease of the vulva: an annotated review of the current literature. Australas J Dermatol. 2013;54:9–21.CrossRefPubMed
22.
go back to reference Shaco-Levy R, Bean SM, Vollmer RT, Jewell E, Jones EL, Valdes CL, Bentley RC, Selim MA, Robboy SJ. Paget disease of the vulva: a study of 56 cases. Eur J Obstet Gynecol Reprod Biol. 2010;149:86–91.CrossRefPubMed Shaco-Levy R, Bean SM, Vollmer RT, Jewell E, Jones EL, Valdes CL, Bentley RC, Selim MA, Robboy SJ. Paget disease of the vulva: a study of 56 cases. Eur J Obstet Gynecol Reprod Biol. 2010;149:86–91.CrossRefPubMed
23.
go back to reference Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecol Oncol. 2007;104:547–50.CrossRefPubMed Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecol Oncol. 2007;104:547–50.CrossRefPubMed
24.
go back to reference Tebes S, Cardosi R, Hoffman M. Paget's disease of the vulva. Am J Obstet Gynecol. 2002;187:281–4.CrossRefPubMed Tebes S, Cardosi R, Hoffman M. Paget's disease of the vulva. Am J Obstet Gynecol. 2002;187:281–4.CrossRefPubMed
25.
go back to reference van der Linden M, Meeuwis KA, Bulten J, Bosse T, van Poelgeest MI, de Hullu JA. Paget disease of the vulva. Crit Rev Oncol Hematol. 2016 May;101:60–74.CrossRefPubMed van der Linden M, Meeuwis KA, Bulten J, Bosse T, van Poelgeest MI, de Hullu JA. Paget disease of the vulva. Crit Rev Oncol Hematol. 2016 May;101:60–74.CrossRefPubMed
26.
go back to reference Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Gilks CB. Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol. 1999;18:351–9.CrossRefPubMed Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Gilks CB. Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol. 1999;18:351–9.CrossRefPubMed
27.
go back to reference Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol. 1997;64:496–500.CrossRefPubMed Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol. 1997;64:496–500.CrossRefPubMed
28.
go back to reference Näyhä VV, Stenbäck FG. Increased angiogenesis is associated with poor prognosis of squamous cell carcinoma of the vulva. Acta Obstet Gynecol Scand. 2007;86:1392–7.CrossRefPubMed Näyhä VV, Stenbäck FG. Increased angiogenesis is associated with poor prognosis of squamous cell carcinoma of the vulva. Acta Obstet Gynecol Scand. 2007;86:1392–7.CrossRefPubMed
29.
go back to reference Siemerink MJ, Klaassen I, Van Noorden CJ, Schlingemann RO. Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy. J Histochem Cytochem. 2013;61:101–15.CrossRefPubMedPubMedCentral Siemerink MJ, Klaassen I, Van Noorden CJ, Schlingemann RO. Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy. J Histochem Cytochem. 2013;61:101–15.CrossRefPubMedPubMedCentral
30.
go back to reference Xu X, Shao N, Qiao D, Wang Z, Song N, Song N. Expression of vascular endothelial growth factor and basic fibroblast growth factor in extramammary Paget disease. Int J Clin Exp Pathol. 2015;8:3062–8.PubMedPubMedCentral Xu X, Shao N, Qiao D, Wang Z, Song N, Song N. Expression of vascular endothelial growth factor and basic fibroblast growth factor in extramammary Paget disease. Int J Clin Exp Pathol. 2015;8:3062–8.PubMedPubMedCentral
31.
go back to reference Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget's disease of the vulva. Cochrane Database Syst Rev. 2013;10:CD009245. Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget's disease of the vulva. Cochrane Database Syst Rev. 2013;10:CD009245.
Metadata
Title
Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression
Authors
Lara Alessandrini
Nicolò Clemente
Tiziana Perin
Giorgio Giorda
Vincenzo Canzonieri
Francesco Sopracordevole
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2018
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-017-0680-x

Other articles of this Issue 1/2018

Diagnostic Pathology 1/2018 Go to the issue